- Is Pancreatic Cancer North America a tax-exempt 501(c)(3)?
- Yes. Pancreatic Cancer North America is recognised by the IRS as a 501(c)(3) organisation (EIN 84-5185853). The IRS recognised Pancreatic Cancer North America as tax-exempt in July 2020.
- What is Pancreatic Cancer North America's EIN?
- Pancreatic Cancer North America's Employer Identification Number (EIN) is 84-5185853. The EIN was assigned by the IRS in July 2020. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Pancreatic Cancer North America do?
- Pancreatic Cancer North America, Inc. aims to fundamentally change the experience of Pancreatic Cancer for patients and their families, and redefine it from a death sentence to a survivable cancer.
- Where is Pancreatic Cancer North America located?
- Pancreatic Cancer North America is located at 800 Third Avenue FRNT A -1523, New York, NY, 10022.
- When was Pancreatic Cancer North America founded or recognised by the IRS?
- Pancreatic Cancer North America was recognised by the IRS as a tax-exempt organisation in July 2020. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Pancreatic Cancer North America's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Pancreatic Cancer North America reported $316K in total revenue and $331K in total expenses.
- Has Pancreatic Cancer North America been auto-revoked by the IRS?
- No. Pancreatic Cancer North America (EIN 84-5185853) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Pancreatic Cancer North America listed in IRS Publication 78?
- Yes. Pancreatic Cancer North America is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
